Renato Mantegazza (R E Mantegazza)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 50

Top Venues

European journal of neurology

Biomedicines

Therapeutic advances in neurological disorders

Expert opinion on biological therapy

Fondazione IRCCS Istituto Neurologico Carlo Besta

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Fondazione IRCCS Istituto Neurologico Carlo Besta

Italy

Head :: Neuroimmunology and Neuromuscular Diseases

Publications

James F Howard, Saskia Bresch, Constantine Farmakidis, Miriam Freimer, Angela Genge, Channa Hewamadduma, John Hinton, Yessar Hussain, Raul Juntas-Morales, Henry J Kaminski, Angelina Maniaol, Renato Mantegazza, Masayuki Masuda, Richard J Nowak, Kumaraswamy Sivakumar, Marek Śmiłowski, Kimiaki Utsugisawa, Tuan Vu, Michael D Weiss, Małgorzata Zajda, Jos Bloemers, Babak Boroojerdi, Melissa Brock, Guillemette de la Borderie, Petra W Duda, Mark Vanderkelen, M Isabel Leite, null null
Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension study. Therapeutic advances in neurological disorders 17 (2024)
Rita Frangiamore, Elena Rinaldi, Fiammetta Vanoli, Francesca Andreetta, Emilio Ciusani, Silvia Bonanno, Lorenzo Maggi, Annamaria Gallone, Anna Colasuonno, Irene Tramacere, Marta Cheli, Alessandro Pinna, Renato Mantegazza, Carlo Antozzi
Efgartigimod in generalized myasthenia gravis: A real-life experience at a national reference center. European journal of neurology 31 (4) (2024)
Renato Mantegazza, Francesco Saccà, Giovanni Antonini, Domenico Marco Bonifati, Amelia Evoli, Francesco Habetswallner, Rocco Liguori, Elena Pegoraro, Carmelo Rodolico, Angelo Schenone, Manlio Sgarzi, Giovanni Pappagallo
Therapeutic challenges and unmet needs in the management of myasthenia gravis: an Italian expert opinion. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2024)
James F Howard, Saskia Bresch, Constantine Farmakidis, Miriam Freimer, Angela Genge, Channa Hewamadduma, John Hinton, Yessar Hussain, Raul Juntas-Morales, Henry J Kaminski, Angelina Maniaol, Renato Mantegazza, Masayuki Masuda, Richard J Nowak, Kumaraswamy Sivakumar, Marek Śmiłowski, Kimiaki Utsugisawa, Tuan Vu, Michael D Weiss, Małgorzata Zajda, Jos Bloemers, Babak Boroojerdi, Melissa Brock, Guillemette de la Borderie, Petra W Duda, Mark Vanderkelen, M Isabel Leite, null null
Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension study. Therapeutic advances in neurological disorders 17 (2024)
Rita Frangiamore, Elena Rinaldi, Fiammetta Vanoli, Francesca Andreetta, Emilio Ciusani, Silvia Bonanno, Lorenzo Maggi, Annamaria Gallone, Anna Colasuonno, Irene Tramacere, Marta Cheli, Alessandro Pinna, Renato Mantegazza, Carlo Antozzi
Efgartigimod in generalized myasthenia gravis: A real-life experience at a national reference center. European journal of neurology 31 (4) (2024)
Rita Frangiamore, Elena Rinaldi, Fiammetta Vanoli, Francesca Andreetta, Emilio Ciusani, Silvia Bonanno, Lorenzo Maggi, Annamaria Gallone, Anna Colasuonno, Irene Tramacere, Marta Cheli, Alessandro Pinna, Renato Mantegazza, Carlo Antozzi
Efgartigimod in generalized myasthenia gravis: A real-life experience at a national reference center. European journal of neurology (2024)
Rita Frangiamore, Elena Rinaldi, Fiammetta Vanoli, Francesca Andreetta, Emilio Ciusani, Silvia Bonanno, Lorenzo Maggi, Annamaria Gallone, Anna Colasuonno, Irene Tramacere, Marta Cheli, Alessandro Pinna, Renato Mantegazza, Carlo Antozzi
Efgartigimod in generalized myasthenia gravis: A real-life experience at a national reference center. European journal of neurology 31 (4) (2024)
Thomas H Brannagan, Sabrina Sacconi, Giovanni Antonini, Elena Cortés-Vicente, Julian Grosskreutz, Zabeen K Mahuwala, Renato Mantegazza, Robert M Pascuzzi, Kimiaki Utsugisawa, John Vissing, Tuan Vu, Heinz Wiendl, Marion Boehnlein, Bernhard Greve, Franz Woltering, Vera Bril
Efficacy and safety of rozanolixizumab in patients with muscle-specific tyrosine kinase autoantibody-positive generalised myasthenia gravis: a subgroup analysis of the randomised, double-blind, placebo-controlled, adaptive phase III MycarinG study. Therapeutic advances in neurological disorders 17 (2024)
James F Howard, Saskia Bresch, Constantine Farmakidis, Miriam Freimer, Angela Genge, Channa Hewamadduma, John Hinton, Yessar Hussain, Raul Juntas-Morales, Henry J Kaminski, Angelina Maniaol, Renato Mantegazza, Masayuki Masuda, Richard J Nowak, Kumaraswamy Sivakumar, Marek Śmiłowski, Kimiaki Utsugisawa, Tuan Vu, Michael D Weiss, Małgorzata Zajda, Jos Bloemers, Babak Boroojerdi, Melissa Brock, Guillemette de la Borderie, Petra W Duda, Mark Vanderkelen, M Isabel Leite, null null
Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension study. Therapeutic advances in neurological disorders 17 (2024)
Vera Bril, James F Howard, Chafic Karam, Jan L De Bleecker, Hiroyuki Murai, Kimiaki Utsugisawa, Peter Ulrichts, Edward Brauer, Sihui Zhao, Renato Mantegazza, Tuan Vu, null null
Effect of efgartigimod on muscle group subdomains in participants with generalized myasthenia gravis: post hoc analyses of the phase 3 pivotal ADAPT study. European journal of neurology (2023)
Fiammetta Vanoli, Renato Mantegazza
Ravulizumab for the treatment of myasthenia gravis. Expert opinion on biological therapy 23 (3) (2023)
Eleonora Giagnorio, Claudia Malacarne, Paola Cavalcante, Letizia Scandiffio, Marco Cattaneo, Viviana Pensato, Cinzia Gellera, Nilo Riva, Angelo Quattrini, Eleonora Dalla Bella, Giuseppe Lauria, Renato Mantegazza, Silvia Bonanno, Stefania Marcuzzo
MiR-146a in ALS: Contribution to Early Peripheral Nerve Degeneration and Relevance as Disease Biomarker. International journal of molecular sciences 24 (5) (2023)
Nicola Iacomino, Letizia Scandiffio, Fabio Conforti, Erika Salvi, Maria Cristina Tarasco, Federica Bortone, Stefania Marcuzzo, Ornella Simoncini, Francesca Andreetta, Daniela Pistillo, Emanuele Voulaz, Marco Alloisio, Carlo Antozzi, Renato Mantegazza, Tommaso Martino De Pas, Paola Cavalcante
Muscle and Muscle-like Autoantigen Expression in Myasthenia Gravis Thymus: Possible Molecular Hint for Autosensitization. Biomedicines 11 (3) (2023)
Andreas Meisel, Fulvio Baggi, Anthony Behin, Amelia Evoli, Anna Kostera-Pruszczyk, Renato Mantegazza, Raul Juntas Morales, Anna Rostedt Punga, Sabrina Sacconi, Michael Schroeter, Jan J G M Verschuuren, Louise Crathorne, Kris Holmes, Maria-Isabel Leite
Reply to the Letter to the Editor in response to "Role of autoantibody levels as biomarkers in the management of patients with myasthenia gravis: A systematic review and expert appraisal". European journal of neurology 30 (4) (2023)
Andreas Meisel, Fulvio Baggi, Anthony Behin, Amelia Evoli, Anna Kostera-Pruszczyk, Renato Mantegazza, Raul Juntas Morales, Anna Rostedt Punga, Sabrina Sacconi, Michael Schroeter, Jan J G M Verschuuren, Louise Crathorne, Kris Holmes, Maria-Isabel Leite
Reply to the Letter to the Editor in response to "Role of autoantibody levels as biomarkers in the management of patients with myasthenia gravis: A systematic review and expert appraisal". European journal of neurology 30 (4) (2023)
Fiammetta Vanoli, Renato Mantegazza
Ravulizumab for the treatment of myasthenia gravis. Expert opinion on biological therapy 23 (3) (2023)
Christos Stergiou, Rhys Williams, Jennifer R Fleming, Vasiliki Zouvelou, Elpinickie Ninou, Francesca Andreetta, Elena Rinaldi, Ornella Simoncini, Renato Mantegazza, Julijus Bogomolovas, John Tzartos, Siegfried Labeit, Patricia Murray, Socrates Tzartos
Immunological and Structural Characterization of Titin Main Immunogenic Region; I110 Domain Is the Target of Titin Antibodies in Myasthenia Gravis. Biomedicines 11 (2) (2023)
Andreas Meisel, Fulvio Baggi, Anthony Behin, Amelia Evoli, Anna Kostera-Pruszczyk, Renato Mantegazza, Raul Juntas Morales, Anna Rostedt Punga, Sabrina Sacconi, Michael Schroeter, Jan J G M Verschuuren, Louise Crathorne, Kris Holmes, Maria-Isabel Leite
Reply to the Letter to the Editor in response to "Role of autoantibody levels as biomarkers in the management of patients with myasthenia gravis: A systematic review and expert appraisal". European journal of neurology 30 (4) (2023)
Fiammetta Vanoli, Renato Mantegazza
Ravulizumab for the treatment of myasthenia gravis. Expert opinion on biological therapy (2023)
Rita Frangiamore, Elena Rinaldi, Fiammetta Vanoli, Francesca Andreetta, Renato Mantegazza, Carlo Antozzi
Efgartigimod improves triple-negative myasthenia gravis. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2023)
Nicola Iacomino, Letizia Scandiffio, Fabio Conforti, Erika Salvi, Maria Cristina Tarasco, Federica Bortone, Stefania Marcuzzo, Ornella Simoncini, Francesca Andreetta, Daniela Pistillo, Emanuele Voulaz, Marco Alloisio, Carlo Antozzi, Renato Mantegazza, Tommaso Martino De Pas, Paola Cavalcante
Muscle and Muscle-like Autoantigen Expression in Myasthenia Gravis Thymus: Possible Molecular Hint for Autosensitization. Biomedicines 11 (3) (2023)
Christos Stergiou, Rhys Williams, Jennifer R Fleming, Vasiliki Zouvelou, Elpinickie Ninou, Francesca Andreetta, Elena Rinaldi, Ornella Simoncini, Renato Mantegazza, Julijus Bogomolovas, John Tzartos, Siegfried Labeit, Patricia Murray, Socrates Tzartos
Immunological and Structural Characterization of Titin Main Immunogenic Region; I110 Domain Is the Target of Titin Antibodies in Myasthenia Gravis. Biomedicines 11 (2) (2023)
Andreas Meisel, Fulvio Baggi, Anthony Behin, Amelia Evoli, Anna Kostera-Pruszczyk, Renato Mantegazza, Raul Juntas Morales, Anna Rostedt Punga, Sabrina Sacconi, Michael Schroeter, Jan J G M Verschuuren, Louise Crathorne, Kris Holmes, Maria-Isabel Leite
Reply to the Letter to the Editor in response to "Role of autoantibody levels as biomarkers in the management of patients with myasthenia gravis: A systematic review and expert appraisal". European journal of neurology (2023)
Eleonora Giagnorio, Claudia Malacarne, Paola Cavalcante, Letizia Scandiffio, Marco Cattaneo, Viviana Pensato, Cinzia Gellera, Nilo Riva, Angelo Quattrini, Eleonora Dalla Bella, Giuseppe Lauria, Renato Mantegazza, Silvia Bonanno, Stefania Marcuzzo
MiR-146a in ALS: Contribution to Early Peripheral Nerve Degeneration and Relevance as Disease Biomarker. International journal of molecular sciences 24 (5) (2023)
Fiammetta Vanoli, Renato Mantegazza
Ravulizumab for the treatment of myasthenia gravis. Expert opinion on biological therapy (2023)
Eleonora Giagnorio, Claudia Malacarne, Paola Cavalcante, Letizia Scandiffio, Marco Cattaneo, Viviana Pensato, Cinzia Gellera, Nilo Riva, Angelo Quattrini, Eleonora Dalla Bella, Giuseppe Lauria, Renato Mantegazza, Silvia Bonanno, Stefania Marcuzzo
MiR-146a in ALS: Contribution to Early Peripheral Nerve Degeneration and Relevance as Disease Biomarker. International journal of molecular sciences 24 (5) (2023)
Andreas Meisel, Fulvio Baggi, Anthony Behin, Amelia Evoli, Anna Kostera-Pruszczyk, Renato Mantegazza, Raul Juntas Morales, Anna Rostedt Punga, Sabrina Sacconi, Michael Schroeter, Jan J G M Verschuuren, Louise Crathorne, Kris Holmes, Maria-Isabel Leite
Reply to the Letter to the Editor in response to "Autoantibody levels as biomarkers of disease activity in management of myasthenia gravis: A systematic review and expert appraisal". European journal of neurology (2023)
Carlo Antozzi, Renato Mantegazza
Impact of Ravulizumab on Patient Outcomes and Quality of Life in Generalized Myasthenia Gravis. Patient related outcome measures 14 (2023)
Christos Stergiou, Rhys Williams, Jennifer R Fleming, Vasiliki Zouvelou, Elpinickie Ninou, Francesca Andreetta, Elena Rinaldi, Ornella Simoncini, Renato Mantegazza, Julijus Bogomolovas, John Tzartos, Siegfried Labeit, Patricia Murray, Socrates Tzartos
Immunological and Structural Characterization of Titin Main Immunogenic Region; I110 Domain Is the Target of Titin Antibodies in Myasthenia Gravis. Biomedicines 11 (2) (2023)
Andreas Meisel, Djillali Annane, Tuan Vu, Renato Mantegazza, Masahisa Katsuno, Rasha Aguzzi, Glen Frick, Laura Gault, James F Howard, null null
Long-term efficacy and safety of ravulizumab in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis: results from the phase 3 CHAMPION MG open-label extension. Journal of neurology (2023)
Andreas Meisel, Djillali Annane, Tuan Vu, Renato Mantegazza, Masahisa Katsuno, Rasha Aguzzi, Glen Frick, Laura Gault, James F Howard, null null
Long-term efficacy and safety of ravulizumab in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis: results from the phase 3 CHAMPION MG open-label extension. Journal of neurology (2023)
Fiammetta Vanoli, Renato Mantegazza
Reply to: Intravenous immunoglobulin (Gamunex® 10%) is licensed for the treatment of severe acute exacerbations of myasthenia gravis. Expert opinion on pharmacotherapy (2023)
Sarah Dewilde, Mathieu F Janssen, Nafthali H Tollenaar, Fiammetta Vanoli, Rita Frangiamore, Glenn Phillips, Sandra Paci, Renato Mantegazza, Andreas Meisel, Frauke Stascheit
Concordance between patient- and physician-reported Myasthenia Gravis Activities of Daily Living (MG-ADL) scores. Muscle & nerve (2023)
Fiammetta Vanoli, Renato Mantegazza
What are the pharmacotherapeutic considerations for the treatment of myasthenia gravis? Expert opinion on pharmacotherapy 23 (13) (2022)
Fiammetta Vanoli, Renato Mantegazza
Antibody Therapies in Autoimmune Neuromuscular Junction Disorders: Approach to Myasthenic Crisis and Chronic Management. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 19 (3) (2022)
Lorenzo Maggi, Luca Bello, Silvia Bonanno, Alessandra Govoni, Claudia Caponnetto, Luigia Passamano, Marina Grandis, Francesca Trojsi, Federica Cerri, Alice Gardani, Manfredi Ferraro, Giulio Gadaleta, Vittoria Zangaro, Luca Caumo, Mariantonietta Maioli, Raffaella Tanel, Elena Saccani, Megi Meneri, Veria Vacchiano, Giulia Ricci, Gianni Sorarù, Eustachio D'Errico, Sara Bortolani, Giovanni Pavesi, Cinzia Gellera, Riccardo Zanin, Stefania P Corti, Mauro Silvestrini, Luisa Politano, Angelo Schenone, Previtali Stefano Carlo, Angela Berardinelli, Mara Turri, Lorenzo Verriello, Michela Coccia, Renato Mantegazza, Rocco Liguori, Massimiliano Mirabella, Gianni Marrosu, Francesco Danilo Tiziano, Gabriele Siciliano, Isabella Laura Simone, Tiziana Mongini, Giacomo Comi, Elena Pegoraro
Adults with spinal muscular atrophy: a large-scale natural history study shows gender effect on disease. Journal of neurology, neurosurgery, and psychiatry 93 (12) (2022)
Nicola Iacomino, Fiammetta Vanoli, Rita Frangiamore, Marta Ballardini, Letizia Scandiffio, Federica Bortone, Francesca Andreetta, Fulvio Baggi, Pia Bernasconi, Carlo Antozzi, Paola Cavalcante, Renato Mantegazza
Complement Activation Profile in Myasthenia Gravis Patients: Perspectives for Tailoring Anti-Complement Therapy. Biomedicines 10 (6) (2022)
Qiang Gang, Conceição Bettencourt, Stefen Brady, Janice L Holton, Estelle G Healy, John McConville, Patrick J Morrison, Michela Ripolone, Raffaella Violano, Monica Sciacco, Maurizio Moggio, Marina Mora, Renato Mantegazza, Simona Zanotti, Zhaoxia Wang, Yun Yuan, Wei-Wei Liu, David Beeson, Michael Hanna, Henry Houlden
Genetic defects are common in myopathies with tubular aggregates. Annals of clinical and translational neurology 9 (1) (2021)
Rita Frangiamore, Riccardo Giossi, Fiammetta Vanoli, Athanasia Tourlaki, Lucia Brambilla, Lorenzo Maggi, Renato Mantegazza
Iatrogenic Kaposi's sarcoma in myasthenia gravis: learnings from two case reports. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 42 (5) (2021)
Eleonora Giagnorio, Claudia Malacarne, Renato Mantegazza, Silvia Bonanno, Stefania Marcuzzo
MyomiRs and their multifaceted regulatory roles in muscle homeostasis and amyotrophic lateral sclerosis. Journal of cell science 134 (12) (2021)
Claudia Malacarne, Mariarita Galbiati, Eleonora Giagnorio, Paola Cavalcante, Franco Salerno, Francesca Andreetta, Cinzia Cagnoli, Michela Taiana, Monica Nizzardo, Stefania Corti, Viviana Pensato, Anna Venerando, Cinzia Gellera, Silvia Fenu, Davide Pareyson, Riccardo Masson, Lorenzo Maggi, Eleonora Dalla Bella, Giuseppe Lauria, Renato Mantegazza, Pia Bernasconi, Angelo Poletti, Silvia Bonanno, Stefania Marcuzzo
Dysregulation of Muscle-Specific MicroRNAs as Common Pathogenic Feature Associated with Muscle Atrophy in ALS, SMA and SBMA: Evidence from Animal Models and Human Patients. International journal of molecular sciences 22 (11) (2021)
Renato Mantegazza, Fanny L O'Brien, Marcus Yountz, James F Howard, null null
Consistent improvement with eculizumab across muscle groups in myasthenia gravis. Annals of clinical and translational neurology 7 (8) (2020)
Renato Mantegazza, Gil I Wolfe, Srikanth Muppidi, Heinz Wiendl, Kenji P Fujita, Fanny L O'Brien, Heather D E Booth, James F Howard, null null
Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension. Neurology 96 (4) (2020)
Renato Mantegazza, Fiammetta Vanoli, Rita Frangiamore, Paola Cavalcante
Complement Inhibition for the Treatment of Myasthenia Gravis. ImmunoTargets and therapy 9 (2020)
Henning Andersen, Renato Mantegazza, Jing Jing Wang, Fanny O'Brien, Kaushik Patra, James F Howard, null null
Eculizumab improves fatigue in refractory generalized myasthenia gravis. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 28 (8) (2019)
Cristina Cappelletti, Franco Salerno, Eleonora Canioni, Marina Mora, Renato Mantegazza, Pia Bernasconi, Lorenzo Maggi
Up-regulation of Toll-like receptors 7 and 9 and its potential implications in the pathogenic mechanisms of LMNA-related myopathies. Nucleus (Austin, Tex.) 9 (1) (2019)
Renato Mantegazza
Amifampridine tablets for the treatment of Lambert-Eaton myasthenic syndrome. Expert review of clinical pharmacology 12 (11) (2019)
Chiara Zecca, G Bellavia, L Brambilla, L P Gutierrez, C Gerardi, A M Fiori, L R Bernardini, G Camera, G Disanto, L Petrini, J Perugini, C G Antozzi, V Torri Clerici, A Bellino, P A Confalonieri, Claudio Gobbi, Renato Mantegazza, S Rossi
Atypical Post-Injection Reactions with Delayed Onset Following Glatiramer Acetate 40 mg: Need for Titration? CNS drugs 32 (7) (2019)
Stefania Marcuzzo, Davide Isaia, Silvia Bonanno, Claudia Malacarne, Paola Cavalcante, Antonella Zacheo, Valentino Laquintana, Nunzio Denora, Barbara Sanavio, Elisa Salvati, Patrizia Andreozzi, Francesco Stellacci, Silke Krol, Maravillas Mellado-López, Renato Mantegazza, Victoria Moreno Manzano, Pia Bernasconi
FM19G11-Loaded Gold Nanoparticles Enhance the Proliferation and Self-Renewal of Ependymal Stem Progenitor Cells Derived from ALS Mice. Cells 8 (3) (2019)
Silvia Bonanno, Maria Barbara Pasanisi, Rita Frangiamore, Lorenzo Maggi, Carlo Antozzi, Francesca Andreetta, Angela Campanella, Greta Brenna, Lorenzo Cottini, Renato Mantegazza
Amifampridine phosphate in the treatment of muscle-specific kinase myasthenia gravis: a phase IIb, randomized, double-blind, placebo-controlled, double crossover study. SAGE open medicine 6 (2018)
Renato Mantegazza, Andreas Meisel, Joern P Sieb, Gwendal Le Masson, Claude Desnuelle, Mirko Essing
The European LEMS Registry: Baseline Demographics and Treatment Approaches. Neurology and therapy 4 (2) (2015)

Renato Mantegazza.css-eqlu8i{font-size:small;padding-left:4px;} (R E Mantegazza)

Publication Activity (10 Years)

Top Topics

Top Venues

Renato Mantegazza (R E Mantegazza)